Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort studyRobert Gilmore, Jakob Begun, Rupert W. Leong et al.|Intestinal Research|2024Cited by 13